Search / Trial NCT06616103

Quantitative CT Imaging Parameters for Assessing Hepatic Steatosis in CHB

Launched by SEOUL NATIONAL UNIVERSITY HOSPITAL · Sep 24, 2024

Trial Information

Current as of October 08, 2024

Not yet recruiting

Keywords

Description

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * chronic hepatitis B
  • * no chronic liver disease other than chronic hepatitis B
  • * Body mass index \>= 23
  • Exclusion Criteria:
  • * pregnant women
  • * unable to perform MRI examinations due to claustrophobia or metallic foreign body
  • * suspicious hepatic malignancy on previous imaging studies
  • * history of local treatment for hepatic lesions
  • * history of surgery or catheter insertion of liver or spleen

About Seoul National University Hospital

Seoul National University Hospital (SNUH) is a leading medical institution in South Korea, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent clinical trial sponsor, SNUH integrates cutting-edge scientific inquiry with patient-centered care, facilitating the development of novel therapies and treatment protocols. The hospital boasts a diverse range of specialized departments and a robust infrastructure for conducting clinical studies, ensuring rigorous adherence to ethical standards and regulatory compliance. By fostering collaboration among multidisciplinary teams, SNUH aims to contribute significantly to global medical advancements and improve patient outcomes.

Locations

Seoul, , Korea, Republic Of

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0